Beranda › Melanoma Uveal › Tennessee › Nashville
Uji klinis Melanoma Uveal di Nashville, TN
6 studi untuk Melanoma Uveal mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
Menerima pesertaFase 3
- Sarah Cannon Research Institute (SCRI), Nashville
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Menerima pesertaFase 1/2
- Sarah Cannon Research Institute, Nashville
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Menerima pesertaFase 1/2
- The Sarah Cannon Research Institute/Tennessee Oncology, Nashville
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Menerima pesertaFase 3
- SCRI Oncology Partners, Nashville
- Vanderbilt Eye Institute, Nashville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Menerima pesertaFase 2/3
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Menerima pesertaFase 1/2
- SCRI Oncology Partners, Nashville
Uji klinis Melanoma Uveal di kota lain
- Philadelphia, PA7 studi
- Los Angeles, CA6 studi
- Boston, MA5 studi
- Scottsdale, AZ5 studi
- New York City, NY5 studi
- Columbus, OH5 studi
- Houston, TX5 studi
- Denver, CO5 studi
- Pittsburgh, PA4 studi
- Aurora, CO4 studi
- Mountain View, CA4 studi
- Miami, FL4 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.